Literature DB >> 15275097

Sterol biosynthesis inhibitors: potential chemotherapeutics against Chagas disease.

R Docampo1, G A Schmuñis.   

Abstract

Entities:  

Year:  1997        PMID： 15275097     DOI： 10.1016/s0169-4758(97)01021-1

Source DB:  PubMed          Journal:  Parasitol Today        ISSN： 0169-4758


× No keyword cloud information.
  11 in total

1.  Cloning and functional expression of a gene encoding a vacuolar-type proton-translocating pyrophosphatase from Trypanosoma cruzi.

Authors:  J E Hill; D A Scott; S Luo; R Docampo
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

2.  Kinetic characterization of squalene synthase from Trypanosoma cruzi: selective inhibition by quinuclidine derivatives.

Authors:  Marco Sealey-Cardona; Simon Cammerer; Simon Jones; Luis M Ruiz-Pérez; Reto Brun; Ian H Gilbert; Julio A Urbina; Dolores González-Pacanowska
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

3.  Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors.

Authors:  F S Buckner; J H Griffin; A J Wilson; W C Van Voorhis
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 4.  Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?

Authors:  Galina I Lepesheva
Journal:  Expert Opin Drug Discov       Date:  2013-09-30       Impact factor: 6.098

5.  Aryloxyethyl Thiocyanates Are Potent Growth Inhibitors of Trypanosoma cruzi and Toxoplasma gondii.

Authors:  María N Chao; Carolina Exeni Matiuzzi; Melissa Storey; Catherine Li; Sergio H Szajnman; Roberto Docampo; Silvia N J Moreno; Juan B Rodriguez
Journal:  ChemMedChem       Date:  2015-04-27       Impact factor: 3.466

6.  Proteomics in Trypanosoma cruzi--localization of novel proteins to various organelles.

Authors:  Marcela Ferella; Daniel Nilsson; Hamid Darban; Claudia Rodrigues; Esteban J Bontempi; Roberto Docampo; Björn Andersson
Journal:  Proteomics       Date:  2008-07       Impact factor: 3.984

7.  Fluorine-containing aryloxyethyl thiocyanate derivatives are potent inhibitors of Trypanosoma cruzi and Toxoplasma gondii proliferation.

Authors:  Guadalupe García Liñares; Santiago Gismondi; Nicolás Osa Codesido; Silvia N J Moreno; Roberto Docampo; Juan B Rodriguez
Journal:  Bioorg Med Chem Lett       Date:  2007-07-13       Impact factor: 2.823

8.  Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae.

Authors:  Simonetta Oliaro-Bosso; Maurizio Ceruti; Gianni Balliano; Paola Milla; Flavio Rocco; Franca Viola
Journal:  Lipids       Date:  2005-12       Impact factor: 1.880

9.  Induction of resistance to azole drugs in Trypanosoma cruzi.

Authors:  F S Buckner; A J Wilson; T C White; W C Van Voorhis
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit.

Authors:  Chiung-Kuang Chen; Patricia S Doyle; Liudmila V Yermalitskaya; Zachary B Mackey; Kenny K H Ang; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.